Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue)
Dissecting mTOR Pathway Mosaicism in FCDII-Harbouring Epileptic Brain and Peripheral Tissue.
King's College Hospital NHS Trust
60 participants
Apr 9, 2023
INTERVENTIONAL
Conditions
Summary
Focal cortical dysplasia (FCD) is a malformation of brain development, the most common cause of drug-resistant epilepsy and often caused by mutations in mammalian target of rapamycin (mTOR) pathway genes. Patients with FCD develop drug-resistant seizures. This study will look at FCD tissue removed during epilepsy surgery and aims to detect mutations in mTOR pathway genes in brain cells. Secondly, the investigators will establish if evidence of mutations found in brain cells can also be detected as circulating free DNA (cfDNA) in blood. By looking at which genes are made into proteins in individual cells found in epilepsy surgical tissue (single cell expression profiling),the investigators will attempt to identify new genetic targets in FCD. The main outcome will be finding new causes of epilepsy with FCD and the development of new diagnostic and screening tools.
Eligibility
Inclusion Criteria5
- Epilepsy in Focal Cortical Dysplasia Type IIA/B
- Adult and Paediatric Patients (male and female)
- A histologically proven diagnosis of FCDIIA/B or a suspected diagnosis of FCDIIA/B (on MRI/EEG and PET grounds) awaiting resective Epilepsy surgery.
- Able to attend appointment/hospital and undergo sampling of serum and nasal swab
- Informed Consent Available
Exclusion Criteria2
- Any acute or chronic conditions that could limit the ability of the patient to participate in the study.
- Refusal to give informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Genetic screening of DNA samples (blood, mucosal swab, brain tissue) from 60-100 patients with histologically confirmed diagnosis of FCDIIA/B identified from Epilepsy Surgery Databases.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06053671